Needham & Company Reiterates a 'Buy' on Benchmark (BHE); Mixed Results and Guide; Execution and Wins Signals Improvement
Tweet Send to a FriendGet Alerts BHE Hot Sheet
Price: $19.12 -0.1%
Rating Summary:
0 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
0 Buy, 1 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade BHE Now!
Needham & Company reiterates a 'Buy' on Benchmark (NYSE: BHE) price target of $18.50 (from $21.00).
Analyst, Sean K.F. Hannan, said, "Overall, we believe BHE is relatively well positioned in the current environment with a healthy mix of non-traditional market biz and new program momentum to soften the effects of macro challenges. While we acknowledge macro fears have elevated risks, we believe the strength of recent program wins, tangible margin expansion, and an active buyback program should provide a healthy foundation for earnings growth."
"Our 3Q becomes $610M in revs. and $0.30 EPS (incl. opt.), vs. prior $616M & $0.31. For 2012, estimates are $2.46B and $1.21, vs. our previous $2.46B and $1.17."
For an analyst ratings summary and ratings history on Benchmark click here. For more ratings news on Benchmark click here.
Shares of Benchmark closed at $15.09 yesterday, with a 52 week range of $12.01-$18.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Sean K.F. Hannan, said, "Overall, we believe BHE is relatively well positioned in the current environment with a healthy mix of non-traditional market biz and new program momentum to soften the effects of macro challenges. While we acknowledge macro fears have elevated risks, we believe the strength of recent program wins, tangible margin expansion, and an active buyback program should provide a healthy foundation for earnings growth."
"Our 3Q becomes $610M in revs. and $0.30 EPS (incl. opt.), vs. prior $616M & $0.31. For 2012, estimates are $2.46B and $1.21, vs. our previous $2.46B and $1.17."
For an analyst ratings summary and ratings history on Benchmark click here. For more ratings news on Benchmark click here.
Shares of Benchmark closed at $15.09 yesterday, with a 52 week range of $12.01-$18.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Needham & Company Keeps Buy Rating on salesforce (CRM); Results 'Unspectacularly Solid'
- Deutsche Bank Adjusts Dean Foods (DF) Price Target to $13
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & Company, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
